Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Temporal negative priming.

Kahan TA, Slowiaczek LM, Altschuler MR, Harrison ACM.

J Exp Psychol Gen. 2019 Jun 13. doi: 10.1037/xge0000634. [Epub ahead of print]

PMID:
31192636
2.

Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.

Lindemann L, Porter RH, Scharf SH, Kuennecke B, Bruns A, von Kienlin M, Harrison AC, Paehler A, Funk C, Gloge A, Schneider M, Parrott NJ, Polonchuk L, Niederhauser U, Morairty SR, Kilduff TS, Vieira E, Kolczewski S, Wichmann J, Hartung T, Honer M, Borroni E, Moreau JL, Prinssen E, Spooren W, Wettstein JG, Jaeschke G.

J Pharmacol Exp Ther. 2015 Apr;353(1):213-33. doi: 10.1124/jpet.114.222463. Epub 2015 Feb 9.

PMID:
25665805
3.

Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.

Glossop PA, Watson CA, Price DA, Bunnage ME, Middleton DS, Wood A, James K, Roberts D, Strang RS, Yeadon M, Perros-Huguet C, Clarke NP, Trevethick MA, Machin I, Stuart EF, Evans SM, Harrison AC, Fairman DA, Agoram B, Burrows JL, Feeder N, Fulton CK, Dillon BR, Entwistle DA, Spence FJ.

J Med Chem. 2011 Oct 13;54(19):6888-904. doi: 10.1021/jm200884j. Epub 2011 Sep 20.

PMID:
21870878
4.

Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.

Fray MJ, Fish PV, Allan GA, Bish G, Clarke N, Eccles R, Harrison AC, Le Net JL, Phillips SC, Regan N, Sobry C, Stobie A, Wakenhut F, Westbrook D, Westbrook SL, Whitlock GA.

Bioorg Med Chem Lett. 2010 Jun 15;20(12):3788-92. doi: 10.1016/j.bmcl.2010.04.052. Epub 2010 Apr 18.

PMID:
20471260
5.

N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.

Wakenhut F, Allan GA, Fish PV, Fray MJ, Harrison AC, McCoy R, Phillips SC, Ryckmans T, Stobie A, Westbrook D, Westbrook SL, Whitlock GA.

Bioorg Med Chem Lett. 2009 Sep 1;19(17):5078-81. doi: 10.1016/j.bmcl.2009.07.049. Epub 2009 Jul 31. Erratum in: Bioorg Med Chem Lett. 2010 Jan 15;20(2):772. Ryckmans, Thomas [added].

PMID:
19647430
6.

Susceptibility to nontuberculous mycobacterial lung disease.

Sexton P, Harrison AC.

Eur Respir J. 2008 Jun;31(6):1322-33. doi: 10.1183/09031936.00140007. Review.

7.

New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture.

Ritchie SR, Harrison AC, Vaughan RH, Calder L, Morris AJ.

Eur Respir J. 2007 Sep;30(3):501-7. Epub 2007 May 30.

8.

Utilisation of pathology procedures.

Harrison AC.

S Afr Med J. 2007 Apr;97(4):226, 228; author reply 230. No abstract available.

10.

Social rates of return to investment in skills assessment and residency training of international medical graduates in Alberta.

Emery JC, Crutcher RA, Harrison AC, Wright H.

Health Policy. 2006 Dec;79(2-3):165-74. Epub 2006 Jan 18.

PMID:
16412528
11.

Induced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis.

McWilliams T, Wells AU, Harrison AC, Lindstrom S, Cameron RJ, Foskin E.

Thorax. 2002 Dec;57(12):1010-4.

12.

Stirring up pathologist.

Harrison AC.

S Afr Med J. 2002 Feb;92(2):96-7. No abstract available.

PMID:
11894658
13.

Studies of L-arginine transport in bovine aortic endothelial cells.

Casey TE, Harrison AC, Zimmerman JK, Hilderman RH.

Arch Biochem Biophys. 2000 Jul 15;379(2):283-91.

PMID:
10898946
14.

Occupationally acquired tuberculosis in New Zealand.

Walls CB, Calder L, Harrison AC.

N Z Med J. 2000 Apr 14;113(1107):129. No abstract available.

PMID:
10834285
15.

Mycobacterium xenopi lung infection.

Wong CG, Harrison AC, Cornere M, Morris AJ.

N Z Med J. 1999 Dec 10;112(1101):476. No abstract available.

PMID:
10678220
16.

Evaluation of the tuberculin gamma interferon assay: potential to replace the Mantoux skin test.

Pottumarthy S, Morris AJ, Harrison AC, Wells VC.

J Clin Microbiol. 1999 Oct;37(10):3229-32.

17.

Mycobacterial cervical adenitis in Auckland: diagnosis by fine needle aspirate.

Harrison AC, Jayasundera T.

N Z Med J. 1999 Jan 22;112(1080):7-9.

PMID:
10073157
18.

Ocular toxicity from ethambutol: a review of four cases and recommended precautions.

Sivakumaran P, Harrison AC, Marschner J, Martin P.

N Z Med J. 1998 Nov 13;111(1077):428-30. Review.

PMID:
9861923
19.

Automated 96-well solid phase extraction for the determination of doramectin in cattle plasma.

Harrison AC, Walker DK.

J Pharm Biomed Anal. 1998 Jan;16(5):777-83.

PMID:
9535189
20.

Multidrug resistant tuberculosis in Auckland 1988-95.

Cameron RJ, Harrison AC.

N Z Med J. 1997 Apr 11;110(1041):119-22.

PMID:
9140412
21.

Tuberculosis revisited.

Harrison AC.

N Z Med J. 1995 Jul 28;108(1004):301-2. No abstract available.

PMID:
7637947
22.

Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine.

Jewell H, Maggs JL, Harrison AC, O'Neill PM, Ruscoe JE, Park BK.

Xenobiotica. 1995 Feb;25(2):199-217.

PMID:
7618347
23.

The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine.

O'Neill PM, Harrison AC, Storr RC, Hawley SR, Ward SA, Park BK.

J Med Chem. 1994 Apr 29;37(9):1362-70.

PMID:
8176713
24.

Intermittent supervised treatment of tuberculosis at Green Lane Hospital, 1987-8.

Samarasinghe D, Hawken M, Harrison AC.

N Z Med J. 1992 Jun 24;105(936):243-5.

PMID:
1620501
25.

The mechanism of bioactivation and antigen formation of amodiaquine in the rat.

Harrison AC, Kitteringham NR, Clarke JB, Park BK.

Biochem Pharmacol. 1992 Apr 1;43(7):1421-30.

PMID:
1567466
26.

Antiasthma drugs and airway hyperresponsiveness.

Pattemore PK, Asher MI, Harrison AC, Mitchell EA, Rea HH, Stewart AW.

Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):498-9. No abstract available.

PMID:
1599532
27.
28.

Effects of water immersion on cardiac output of lean and fat male subjects at rest and during exercise.

Haffor AS, Mohler JG, Harrison AC.

Aviat Space Environ Med. 1991 Feb;62(2):123-7.

PMID:
1900415
29.

The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms.

Pattemore PK, Asher MI, Harrison AC, Mitchell EA, Rea HH, Stewart AW.

Am Rev Respir Dis. 1990 Sep;142(3):549-54.

PMID:
2202246
30.

Anaerobic threshold alterations caused by interval training in 11-year-olds.

Hoffor AS, Harrison AC, Kirk PA.

J Sports Med Phys Fitness. 1990 Mar;30(1):53-6.

PMID:
2366536
31.

Socioeconomic status in childhood asthma.

Mitchell EA, Stewart AW, Pattemore PK, Asher MI, Harrison AC, Rea HH.

Int J Epidemiol. 1989 Dec;18(4):888-90.

PMID:
2621026
32.

Ethnic differences in prevalence of asthma symptoms and bronchial hyperresponsiveness in New Zealand schoolchildren.

Pattemore PK, Asher MI, Harrison AC, Mitchell EA, Rea HH, Stewart AW.

Thorax. 1989 Mar;44(3):168-76.

33.

International comparison of the prevalence of asthma symptoms and bronchial hyperresponsiveness.

Asher MI, Pattemore PK, Harrison AC, Mitchell EA, Rea HH, Stewart AW, Woolcock AJ.

Am Rev Respir Dis. 1988 Sep;138(3):524-9.

PMID:
3202407
34.

Colour vision abnormalities in multiple sclerosis.

Harrison AC, Becker WJ, Stell WK.

Can J Neurol Sci. 1987 Aug;14(3):279-85.

PMID:
3664369
35.
36.
37.

Inhaled high-dose beclomethasone in chronic asthma.

Karalus NC, Harrison AC.

N Z Med J. 1987 May 27;100(824):306-8. Review.

PMID:
3330185
38.

Referral of asthmatics to a psychologist.

Taylor GH, Rea H, Harrison AC.

N Z Med J. 1986 Dec 10;99(815):960-1. No abstract available.

PMID:
3468436
39.

Tuberculosis at Green Lane Hospital 1980-1982.

Brett W, Harrison AC, Breed MC, Brett A.

N Z Med J. 1986 Sep 24;99(810):705-8.

PMID:
3469561
40.

The management of non-small cell lung cancer.

Harrison AC.

N Z Med J. 1985 Mar 13;98(774):142-4. No abstract available.

PMID:
3856169
41.

Asthma management.

Rea HH, Harrison AC.

N Z Med J. 1985 Jan 23;98(771):31. No abstract available.

PMID:
3855523
42.

Hospital admissions for asthma.

Rea HH, Harrison AC, Harris EA.

N Z Med J. 1984 Mar 28;97(752):199-200. No abstract available.

PMID:
6583580
43.

Further considerations in managing the respiratory cripple.

Harrison AC.

N Z Med J. 1982 Sep 22;95(716):660-1. No abstract available.

PMID:
6957793
44.

Comprehensive management of the respiratory cripple: basic principles.

Harrison AC.

N Z Med J. 1982 Apr 28;95(706):270-1. No abstract available.

PMID:
6953370
45.

Giant condyloma (Buschke--Loewenstein tumor) of the anorectum.

Elliot MS, Werner ID, Immelman EJ, Harrison AC.

Dis Colon Rectum. 1979 Oct;22(7):497-500.

PMID:
527438
46.

Combined cholinergic antagonist and beta 2-adrenoceptor agonist bronchodilator therapy by inhalation.

Marlin GE, Berend N, Harrison AC.

Aust N Z J Med. 1979 Oct;9(5):511-4.

PMID:
161170
47.

Tracheobronchopathia osteochondroplastica.

Berend N, Harrison AC, Hartnett BJ, Lawson J, Marlin GE.

Aust N Z J Med. 1979 Apr;9(2):188-92.

PMID:
287464
48.

Myogenic cells in Kaposi's sarcoma: an ultrastructural study.

Harrison AC, Kahn LB.

J Pathol. 1978 Mar;124(3):157-60. Review.

PMID:
363990
49.

Recurrent venous thrombosis (thrombophlebitis migrans) and carcinoma of the lung.

Harrison AC, Breslin AB.

Med J Aust. 1977 Jun 18;1(25):927-9.

PMID:
887028

Supplemental Content

Loading ...
Support Center